NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Health Information Services · USD

Claritev Corporation (CTEV) Stock Analysis

Claritev Corporation (CTEV) is a Health Information Services stock listed on NYSE and quoted in US Dollar.

CTEV

$38.43

−$0.66 (−1.69%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CTEV with… →

CTEV Key Statistics

As of Sep 4, 2026
Trading
Open
$39.08
Previous Close
$39.09
Day's Range
37.66–39.08
52-Week Range
11.50–74.07
Volume
70.60K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.89
Valuation
Market Cap
$651.29M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
5.24
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.65
EPS (ttm)Profit attributable to each share over the last twelve months.
−16.71
Financials (FY)
Revenue (FY)
$965.41M+3.74%
Net Income (FY)
−$284.28M
Profit marginThe share of revenue left as profit after all costs and taxes.
−28.46%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
16.95M
1-Year Return
−43.20%
Dividend and dates
Earnings Date
November 5, 2026estimated
Avg Volume
119.58K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CTEV Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−10.11%
2025+189.24%
2024−74.34%
2023+25.22%
2022−74.04%
2021−44.56%
2020 (partial year)−17.80%

As of September 4, 2026.

CTEV Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$965.41M−$284.28M−29.4%
2024$930.62M−$1.65B−176.9%
2023$961.52M−$91.70M−9.5%
2022$1.08B−$572.91M−53.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$965.41M$649.05M$45.06M−$284.28M−29.4%
2024$930.62M$627.17M$108.26M−$1.65B−176.9%
2023$961.52M$665.90M$170.92M−$91.70M−9.5%
2022$1.08B$875.62M$334.18M−$572.91M−53.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CTEV Valuation vs Health Information Services Median

Median of 53 stocks
MetricCTEVHealth Information Services medianvs median
P/S ratio0.652.660.2x the median
Profit margin−28.46%0.00%28.5 pts below

Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 17 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Claritev Corporation (CTEV) carries a market capitalisation of $651.29M. It is classified in the Health Information Services industry, within the Healthcare sector. The company reports 3,000 employees.

The 52-week range on file runs from $11.50 to $74.07. The most recent close on file for CTEV is $38.43, dated September 4, 2026. That is −$0.66 (−1.69%) against the previous close. The latest close sits 234.17% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $965.41M. That is +3.74% against the prior fiscal year, when revenue was $930.62M. The same year closed with a net loss of $284.28M. Profit margin runs at −28.46%. That is 28.5 percentage points below the Health Information Services median of 0%. Trailing earnings per share are −16.71.

Across the 4 fiscal years on file, revenue moves from $1.08B in 2022 to $965.41M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 5.24. The price-to-sales ratio is 0.65. On price-to-sales that is 0.2 times the Health Information Services median of 2.66. 53 Health Information Services companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 0.89. Annualized volatility over the trailing 6 years is 105.94%. Over the trailing twelve months the price has returned −43.20%. Across 5 years the annualized return works out at −30.97%.

Growth & Income

The record shows no dividend for CTEV.

The strongest complete calendar year on file is 2025 at +189.24%; the weakest is 2024 at −74.34%. Of the 5 complete calendar years on file, 2 finished higher. 2026 is still running; the price is −10.11% year to date.

Peer Comparison

Claritev Corporation (CTEV) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Claritev Corporation CTEV $651.29M —
Veeva Systems Inc. VEEV $44.54B 45.0
BrightSpring Health Services, Inc. BTSG $12.02B 54.7
Tempus AI, Inc. TEM $11.66B —

The Health Information Services industry average P/E ratio is 41.1x. Claritev Corporation has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$44.54B

 BTSG

BrightSpring Health Services, Inc.

$12.02B

 TEM

Tempus AI, Inc.

$11.66B

 HQY

HealthEquity, Inc.

$7.95B

 HNGE

Hinge Health, Inc.

$7.45B

 WAY

Waystar Holding Corp.

$4.81B
View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Claritev Corporation

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.

Visit website →